News from emd serono, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 05, 2013, 08:00 ET
EMD Serono logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Makes First Awards as Part of the Company's 1 Million Euro Grant for Multiple Sclerosis Innovation

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today on the occasion of the 29th European Committee...

Oct 01, 2013, 09:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is the founding supporter of the newly launched...

May 28, 2013, 09:00 ET
Jan 03, 2013, 10:00 ET
Pfizer logo.  (PRNewsFoto/EMD Serono)

EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a)

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the U.S. Food and Drug...

Dec 20, 2012, 08:00 ET
EMD logo.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono, Inc. and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Fast Forward LLC, a wholly-owned subsidiary of the National Multiple...

Oct 11, 2012, 09:00 ET
EMD Serono Logo 1.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Launches One Million Euro Research Grant for Multiple Sclerosis Innovation

 EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today during the European Committee for Treatment and Research in...

Sep 18, 2012, 09:30 ET
EMD Serono Logo 1.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include U.S. Investigators

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the company has expanded its global program named Grant...

Jan 23, 2012, 08:00 ET

MS LifeLines® Earns J.D. Power and Associates Call Center Certification for Customer Service Excellence in Providing Support Services to the MS Community

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the MS LifeLines® call center...

Apr 29, 2011, 13:53 ET

EMD Serono, Inc. Receives Gold LEED® Rating

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the company's state-of-the-art research center in Billerica,...

Mar 02, 2011, 02:25 ET
EMD Serono Logo 2.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application

ROCKLAND, Mass., March 2, 2011 – EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a...

Feb 11, 2011, 17:36 ET
EMD Serono, Inc. today opened a state-of-the-art research center in Mass.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Holds Grand Opening Ceremony for New State-of-the-Art Research Center in Billerica, MA

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced the opening of a state-of-the-art research center in Billerica,...

Nov 26, 2010, 03:21 ET
EMD Serono Logo 1.  (PRNewsFoto/EMD Serono, Inc.)

EMD Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its...

Nov 11, 2010, 07:35 ET

FDA Approves EGRIFTA™ (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the U.S. Food and Drug Administration (FDA) has approved...

Jul 28, 2010, 03:38 ET

EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for...

Jan 21, 2010, 01:30 ET

Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today the online publication of the results from the CLARITY(1) Phase III...

Dec 16, 2009, 08:00 ET

EMD Serono, Inc. and Nationally Ranked US Hospital Announce Collaboration in Basic and Clinical Research in Multiple Sclerosis

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced a strategic collaboration with Brigham and Women's Hospital in...

Nov 30, 2009, 09:06 ET

EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a refuse to file letter from the US Food and Drug...

Oct 19, 2009, 13:06 ET

Video: EMD Serono Holds Topping Off Ceremony to Mark Milestone in the Expansion of the Company's Billerica, MA Research Facility

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, marked the expansion of its research facility in Billerica, MA today,...

Oct 05, 2009, 10:46 ET

EMD Serono, Inc. Named as a Top Employer by Science Magazine

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that Science magazine has named it one of the world's...

Sep 30, 2009, 12:02 ET

EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States

EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the...